Zhijian Xiao

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Venues

Blood cancer journal

Leukemia

Nature communications

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Fuhui Li, Tiejun Qin, Bing Li, Shiqiang Qu, Lijuan Pan, Peihong Zhang, Qi Sun, Changlu Xu, Qingyan Gao, Meng Jiao, Junjie Li, Xiaofei Ai, Jiao Ma, Robert Peter Gale, Zefeng Xu, Zhijian Xiao
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis. Leukemia 38 (6) (2024)
Peiwen Zhang, Na You, Yiyi Ding, Wenqi Zhu, Nan Wang, Yueqiao Xie, Wanling Huang, Qian Ren, Tiejun Qin, Rongfeng Fu, Lei Zhang, Zhijian Xiao, Tao Cheng, Xiaotong Ma
Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms. Nature communications 15 (1) (2024)
Peiwen Zhang, Na You, Yiyi Ding, Wenqi Zhu, Nan Wang, Yueqiao Xie, Wanling Huang, Qian Ren, Tiejun Qin, Rongfeng Fu, Lei Zhang, Zhijian Xiao, Tao Cheng, Xiaotong Ma
Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms. Nature communications 15 (1) (2024)
Fuhui Li, Tiejun Qin, Bing Li, Shiqiang Qu, Lijuan Pan, Peihong Zhang, Qi Sun, Changlu Xu, Qingyan Gao, Meng Jiao, Junjie Li, Xiaofei Ai, Jiao Ma, Robert Peter Gale, Zefeng Xu, Zhijian Xiao
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis. Leukemia 38 (6) (2024)
Fuhui Li, Tiejun Qin, Bing Li, Shiqiang Qu, Lijuan Pan, Peihong Zhang, Qi Sun, Changlu Xu, Qingyan Gao, Meng Jiao, Junjie Li, Xiaofei Ai, Jiao Ma, Robert Peter Gale, Zefeng Xu, Zhijian Xiao
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis. Leukemia (2024)
Fuhui Li, Tiejun Qin, Bing Li, Shiqiang Qu, Lijuan Pan, Peihong Zhang, Qi Sun, Changlu Xu, Qingyan Gao, Meng Jiao, Junjie Li, Xiaofei Ai, Jiao Ma, Robert Peter Gale, Zefeng Xu, Zhijian Xiao
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis. Leukemia 38 (6) (2024)
Fuhui Li, Tiejun Qin, Bing Li, Shiqiang Qu, Lijuan Pan, Peihong Zhang, Qi Sun, Changlu Xu, Qingyan Gao, Meng Jiao, Junjie Li, Xiaofei Ai, Jiao Ma, Robert Peter Gale, Zefeng Xu, Zhijian Xiao
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis. Leukemia 38 (6) (2024)
Peiwen Zhang, Na You, Yiyi Ding, Wenqi Zhu, Nan Wang, Yueqiao Xie, Wanling Huang, Qian Ren, Tiejun Qin, Rongfeng Fu, Lei Zhang, Zhijian Xiao, Tao Cheng, Xiaotong Ma
Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms. Nature communications 15 (1) (2024)
Xin Yan, Zefeng Xu, Peihong Zhang, Qi Sun, Yujiao Jia, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Zhanqi Li, Jinqin Liu, Zhen Song, Qingyan Gao, Meng Jiao, Jingye Gong, Huijun Wang, Bing Li, Zhijian Xiao
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression. Blood cancer journal 13 (1) (2023)
Xin Yan, Zefeng Xu, Peihong Zhang, Qi Sun, Yujiao Jia, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Zhanqi Li, Jinqin Liu, Zhen Song, Qingyan Gao, Meng Jiao, Jingye Gong, Huijun Wang, Bing Li, Zhijian Xiao
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression. Blood cancer journal 13 (1) (2023)
Xin Yan, Zefeng Xu, Peihong Zhang, Qi Sun, Yujiao Jia, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Zhanqi Li, Jinqin Liu, Zhen Song, Qingyan Gao, Meng Jiao, Jingye Gong, Huijun Wang, Bing Li, Zhijian Xiao
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression. Blood cancer journal 13 (1) (2023)
Xin Yan, Zefeng Xu, Peihong Zhang, Qi Sun, Yujiao Jia, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Zhanqi Li, Jinqin Liu, Zhen Song, Qingyan Gao, Meng Jiao, Jingye Gong, Huijun Wang, Bing Li, Zhijian Xiao
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression. Blood cancer journal 13 (1) (2023)
Xin Yan, Zefeng Xu, Peihong Zhang, Qi Sun, Yujiao Jia, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Zhanqi Li, Jinqin Liu, Zhen Song, Qingyan Gao, Meng Jiao, Jingye Gong, Huijun Wang, Bing Li, Zhijian Xiao
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression. Blood cancer journal 13 (1) (2023)
Xin Yan, Zefeng Xu, Peihong Zhang, Qi Sun, Yujiao Jia, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Zhanqi Li, Jinqin Liu, Zhen Song, Qingyan Gao, Meng Jiao, Jingye Gong, Huijun Wang, Bing Li, Zhijian Xiao
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression. Blood cancer journal 13 (1) (2023)
Xin Yan, Zefeng Xu, Peihong Zhang, Qi Sun, Yujiao Jia, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Zhanqi Li, Jinqin Liu, Zhen Song, Qingyan Gao, Meng Jiao, Jingye Gong, Huijun Wang, Bing Li, Zhijian Xiao
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression. Blood cancer journal 13 (1) (2023)
Xin Yan, Zefeng Xu, Peihong Zhang, Qi Sun, Yujiao Jia, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Zhanqi Li, Jinqin Liu, Zhen Song, Qingyan Gao, Meng Jiao, Jingye Gong, Huijun Wang, Bing Li, Zhijian Xiao
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression. Blood cancer journal 13 (1) (2023)
Yudi Zhang, Junying Wu, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Huijun Wang, Peihong Zhang, Xin Yan, Jingye Gong, Qingyan Gao, Robert Peter Gale, Zhijian Xiao
Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms. Leukemia 36 (12) (2022)
Yudi Zhang, Junying Wu, Zefeng Xu, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Huijun Wang, Qi Sun, Chengwen Li, Yujiao Jia, Wenyu Cai, Xin Yan, Jingye Gong, Qingyan Gao, Bing Li, Robert Peter Gale, Zhijian Xiao
Impact of the International Consensus Classification of myelodysplastic syndromes. British journal of haematology (2022)
Junying Wu, Wenjun Zhang, Peihong Zhang, Tiejun Qin, Zefeng Xu, Qi Sun, Yujiao Jia, Shiqiang Qu, Bing Li, Huijun Wang, Lijuan Pan, Jinqin Liu, Yudi Zhang, Xin Yan, Robert Peter Gale, Zhijian Xiao
Distinguishing myelodysplastic syndromes with moderate-to-severe bone marrow fibrosis from triple-negative primary myelofibrosis based on clinical and genetic covariates. Hematological oncology (2022)
Shiqiang Qu, Zefeng Xu, Tiejun Qin, Bing Li, Lijuan Pan, Jia Chen, Xin Yan, Junying Wu, Yudi Zhang, Peihong Zhang, Robert Peter Gale, Zhijian Xiao
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study. Hematological oncology 40 (4) (2022)
Dan Liu, Zefeng Xu, Peihong Zhang, Tiejun Qin, Bing Li, Shiqiang Qu, Lijuan Pan, Changlu Xu, Jinqin Liu, Huijun Wang, Qi Sun, Xiujuan Sun, Meng Jiao, Qingyan Gao, Zhongxun Shi, Huijun Huang, Gang Huang, Robert Peter Gale, Zhijian Xiao
Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera. Blood cancer journal 11 (9) (2021)
Huijun Huang, Junying Wu, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Wenyu Cai, Jinqin Liu, Huijun Wang, Qi Sun, Meng Jiao, Qingyan Gao, Gang Huang, Robert Peter Gale, Bing Li, Zhijian Xiao
Is race important in genomic classification of hematological neoplasms? Hematological oncology 39 (5) (2021)
Shuhua Yi, Yuting Yan, Meiling Jin, Wenjie Xiong, Zhen Yu, Ying Yu, Rui Cui, Jun Wang, Yi Wang, Yani Lin, Yujiao Jia, Donglei Zhang, Tingyu Wang, Rui Lv, Wei Liu, Weiwei Sui, Wenyang Huang, Mingwei Fu, Yan Xu, Shuhui Deng, Gang An, Dehui Zou, Zengjun Li, Jun Shi, Zhijian Xiao, Jian-Xiang Wang, Tao Cheng, Robert Peter Gale, Lili Wang, Lugui Qiu
High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia. Leukemia 35 (8) (2021)
Huijun Huang, Wenjun Zhang, Wenyu Cai, Jinqin Liu, Huijun Wang, Tiejun Qin, Zefeng Xu, Bing Li, Shiqiang Qu, Lijuan Pan, Gang Huang, Robert Peter Gale, Zhijian Xiao
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder. Experimental hematology & oncology 10 (1) (2021)
Dan Liu, Bing Li, Zefeng Xu, Peihong Zhang, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Xiujuan Sun, Zhongxun Shi, Huijun Huang, Huijun Wang, Robert Peter Gale, Zhijian Xiao
RBC distribution width predicts thrombosis risk in polycythemia vera. Leukemia (2021)
Huijun Huang, Changlu Xu, Jie Gao, Bing Li, Tiejun Qin, Zefeng Xu, Sirui Ren, Yudi Zhang, Meng Jiao, Shiqiang Qu, Lijuan Pan, Naibo Hu, Jinqin Liu, Changlu Xu, Yingnan Zhang, Dan Wu, Peihong Zhang, Robert Peter Gale, Gang Huang, Jiaxi Zhou, Lihong Shi, Zhijian Xiao
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre. Blood cancer journal 10 (8) (2020)

Zhijian Xiao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhijian Xiao